Skip to content
Head to head

Neogen vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: NEOG · ABT

Updated 9 minutes ago

1-year performance, rebased to 100

NEOG +64.3%ABT -19.3%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories pays the highest dividend yield; Abbott Laboratories earns the most per share.
NEOGABT
Snapshot
SectorMedical DevicesMedical Devices
Last price10.55103.00
Change today-2.77%-0.84%
1-year return+95.0%-15.4%
Market cap$2.30B$178.39B
52-week range5.60 – 14.2680.89 – 126.70
Valuation
P/E (TTM)-40.5838.29
P/E percentile, own 5-yr range35th99th
P/B1.103.50
Dividend yield0.00%2.41%
Profitability & growth
EPS (TTM)-0.043.72
Net profit (TTM)$-8.73M$6.44B
Revenue (TTM)$883.99M$48.23B
Provider revenue period date2026-08-302026-09-29
Revenue growth (YoY)+6.5%+14.5%
Gross margin47.4%56.9%
Operating margin-0.8%13.8%
Net margin-6.3%9.7%
Free cash flow (TTM)$49.80M$6.76B
Provider cash-flow period date2026-08-302026-09-29
Ownership & sentiment
Institutional ownership111.0%81.2%
Insider activity (12mo)37 buy / 9 sell36 buy / 12 sell
Short interest (% of float)5.8%1.1%
Analyst consensus67% buy / 33% hold (3)93% buy / 7% hold (15)
Analyst price target$14 (+33%)$122 (+18%)
StockVane view
StockVane Quant RatingC (96)D (22)
Company
Employees817115,000
Founded19811900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.